SUPPLIES Act of 2020
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020 or the SUPPLIES Act of 2020
This bill excludes certain short-dated drugs from rebate calculations under the Medicaid Drug Rebate Program during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). Specifically, the bill excludes from such calculations direct sales of drugs that (1) have a shelf life of one year or more and expire one year after the date of sale, or (2) have a shelf life of less than one year and expire after the same number of days as the shelf life following the date of sale.
Referred to the House Committee on Energy and Commerce.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 8139: SUPPLIES Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-8139/
"H.R. 8139: SUPPLIES Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-8139/.
H.R. 8139, 116th Cong. (2026), https://openamerica.io/bill/116-HR-8139/.
[H.R. 8139: SUPPLIES Act of 2020](https://openamerica.io/bill/116-HR-8139/)